173 related articles for article (PubMed ID: 6574137)
1. Routine flow cytometric diagnosis of lymphoproliferative disorders.
Barr IG; Toh BH
J Clin Immunol; 1983 Apr; 3(2):184-95. PubMed ID: 6574137
[TBL] [Abstract][Full Text] [Related]
2. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
3. Multiparameter analysis of immunohematological disorders by flow cytometry.
Duque RE; Stoolman LM; Hudson JL; Ward PA
Surv Synth Pathol Res; 1985; 4(4):323-40. PubMed ID: 3915390
[No Abstract] [Full Text] [Related]
4. Membrane antigen analysis in the diagnosis of lymphoid leukemias and lymphomas. Differential diagnosis, prognosis as related to immunophenotype, and recommendations for testing.
Deegan MJ
Arch Pathol Lab Med; 1989 Jun; 113(6):606-18. PubMed ID: 2658905
[TBL] [Abstract][Full Text] [Related]
5. [Significance of terminal deoxynucleotidyl transferase in lymphoproliferative diseases].
Telek B; Ember I; Kiss A; Pecze K
Orv Hetil; 1986 Dec; 127(52):3183-6. PubMed ID: 3468473
[No Abstract] [Full Text] [Related]
6. Differential diagnosis of T-cell lymphoproliferative disorders by flow cytometry multicolor immunophenotyping. correlation with morphology.
Gorczyca W
Methods Cell Biol; 2004; 75():595-621. PubMed ID: 15603444
[No Abstract] [Full Text] [Related]
7. Clinical manifestations of chronic leukemias.
Theologides A
Minn Med; 1985 Nov; 68(11):833-5. PubMed ID: 3866140
[No Abstract] [Full Text] [Related]
8. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
Rothe G; Schmitz G
Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of lymphomas and lymphoproliferative disorders.
Stetler-Stevenson M; Braylan RC
Semin Hematol; 2001 Apr; 38(2):111-23. PubMed ID: 11309693
[TBL] [Abstract][Full Text] [Related]
10. [Mouse rosettes in the differential diagnosis of lymphoproliferative disorders].
Gabrielli A; Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
Minerva Med; 1982 May; 73(20):1383-90. PubMed ID: 7043323
[No Abstract] [Full Text] [Related]
11. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
[TBL] [Abstract][Full Text] [Related]
12. [Immunophenotype analysis in 121 patients with lymphoproliferative diseases by flow cytometry].
Sun XM; Chen JH; Xu JY; Zhang YF; Xie PH; Fan XN; Xie W
Ai Zheng; 2004 Aug; 23(8):955-7. PubMed ID: 15301723
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo fine-needle aspiration cytology and flow cytometric phenotyping in the diagnosis of lymphoproliferative disorders: a proposed algorithm for maximum resource utilization.
Saddik M; el Dabbagh L; Mourad WA
Diagn Cytopathol; 1997 Feb; 16(2):126-31. PubMed ID: 9067103
[TBL] [Abstract][Full Text] [Related]
14. The use of monoclonal antibodies in clinical haematology--the art of limitation.
Hokland P
Scand J Haematol; 1984 Jul; 33(1):5-8. PubMed ID: 6611582
[No Abstract] [Full Text] [Related]
15. Lymphoproliferative and myeloproliferative disorders.
Savage CJ
Vet Clin North Am Equine Pract; 1998 Dec; 14(3):563-78, vii. PubMed ID: 9891725
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of chronic lymphocytic leukemia from other "well to intermediate differentiated" lymphoproliferative disorders by the mouse rosette assay.
Hicks MJ; Grogan TM; Fielder K; Spier CM
Diagn Immunol; 1986; 4(1):31-6. PubMed ID: 3456864
[TBL] [Abstract][Full Text] [Related]
17. The use of flow cytometry for immunophenotyping lymphoproliferative disorders in cats: a retrospective study of 19 cases.
Guzera M; Cian F; Leo C; Winnicka A; Archer J
Vet Comp Oncol; 2016 Aug; 14 Suppl 1():40-51. PubMed ID: 24890438
[TBL] [Abstract][Full Text] [Related]
18. Measurement of lymphocyte aggregation by flow cytometry-physiological implications in chronic lymphocytic leukemia.
Dezorella N; Kay S; Baron S; Shapiro M; Porat Z; Deutsch V; Herishanu Y; Katz BZ
Cytometry B Clin Cytom; 2016 May; 90(3):257-66. PubMed ID: 26082241
[TBL] [Abstract][Full Text] [Related]
19. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Carotenuto M
Am J Hematol; 2000 Aug; 64(4):275-81. PubMed ID: 10911380
[TBL] [Abstract][Full Text] [Related]
20. T-lymphocyte malignancies: recent advances in the understanding of their biology, diagnosis and treatment.
Parkinson DR; Mier JW
Clin Immunol Rev; 1983; 2(1):59-121. PubMed ID: 6349892
[No Abstract] [Full Text] [Related]
[Next] [New Search]
